⌘K

Home/Filings/4/0001225208-16-028092

4//SEC Filing

WEST PHARMACEUTICAL SERVICES INC 4

Accession 0001225208-16-028092

$WSTCIK 0000105770operating

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 10:58 AM ET

Size

17.1 KB

Accession

0001225208-16-028092

Insider Transaction Report

Form 4

Period: 2016-02-23

WEST PHARMACEUTICAL SERVICES INCWST

Bedwell Warwick

VP Pharma Pkgs Systems Asia Pa

Transactions

Award
Common Stock
2016-02-23$59.64/sh+4,613$275,119→ 38,778.082 total
Exercise/Conversion
Common Stock
2016-02-23$54.14/sh+3,680$199,235→ 42,458.082 total
Exercise/Conversion
Common Stock
2016-02-24$47.34/sh+3,616$171,181→ 42,394.082 total
Sale
Common Stock
2016-02-24$59.23/sh−3,616$214,193→ 38,778.082 total
Exercise/Conversion
Stock Option (Right to Buy)
2016-02-23$54.14/sh−3,680$199,235→ 11,040 total
Exercise: $54.14From: 2016-02-23Exp: 2025-02-23→ Common Stock (3,680 underlying)
Award
Stock Option (Right to Buy)
2016-02-23$59.64/sh+13,012$776,036→ 13,012 total
Exercise: $59.64From: 2017-02-23Exp: 2026-02-23→ Common Stock (13,012 underlying)
Sale
Common Stock
2016-02-23$58.84/sh−3,680$216,533→ 38,778.082 total
Exercise/Conversion
Stock Option (Right to Buy)
2016-02-24$47.34/sh−3,616$171,181→ 7,232 total
Exercise: $47.34From: 2015-02-24Exp: 2024-02-24→ Common Stock (3,616 underlying)

Footnotes (4)

[F1]Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.
[F2]This was multiple transactions on the same date with prices in the range of $58.69 to $58.98. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
[F3]This was multiple transactions on the same date with prices in the range of $59.01 to $59.40. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
[F4]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

Documents

1 file

4
doc4.xmlPrimary

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeoperating

IncorporatedPA

Related Parties

1

filerCIK 0000105770

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 10:58 AM ET
Size: 17.1 KB

View on SEC.gov